Merck KGaA (ETR:MRK – Get Rating) shot up 1.2% on Friday . The stock traded as high as €162.25 ($176.36) and last traded at €161.35 ($175.38). 154,244 shares changed hands during mid-day trading, The stock had previously closed at €159.45 ($173.32).
Merck KGaA Stock Performance
The company has a market capitalization of $21.51 billion, a price-to-earnings ratio of 21.79, a P/E/G ratio of 6.08 and a beta of 0.63. The company has a debt-to-equity ratio of 40.10, a quick ratio of 0.72 and a current ratio of 1.28. The firm has a 50-day simple moving average of €166.08 and a two-hundred day simple moving average of €176.22.
Merck KGaA Company Profile
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology.
Featured Stories
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
